{"transactions":[{"id":698146,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-08-04T19:06:23.000Z","date":"2026-08-03","kind":"grant","planned":false,"acquired":true,"shares":456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $160,000 by the closing stock price on the grant date."}],"balance_after":21670,"source":{"system":"sec-edgar","filing":"0001225208-26-006921","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520826006921/doc4.xml","form_type":"4"}},{"id":740530,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T21:19:55.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073582","document":"tm2617745-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465926073582/tm2617745-2_4seq1.xml","form_type":"4"}},{"id":740529,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T21:19:55.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":60933,"source":{"system":"sec-edgar","filing":"0001104659-26-073582","document":"tm2617745-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465926073582/tm2617745-2_4seq1.xml","form_type":"4"}},{"id":766656,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T20:15:18.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":2922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,922 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6981,"source":{"system":"sec-edgar","filing":"0001193125-26-236914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000119312526236914/ownership.xml","form_type":"4"}},{"id":1075599,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-08-05T15:56:04.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $130,000 by a 30-day trailing average stock price."}],"balance_after":21214,"source":{"system":"sec-edgar","filing":"0001225208-25-007006","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520825007006/doc4.xml","form_type":"4"}},{"id":1112312,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:25:32.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059389","document":"tm2517945-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465925059389/tm2517945-5_4seq1.xml","form_type":"4"}},{"id":1112311,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T20:25:32.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":46933,"source":{"system":"sec-edgar","filing":"0001104659-25-059389","document":"tm2517945-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465925059389/tm2517945-5_4seq1.xml","form_type":"4"}},{"id":1135948,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-23T22:46:53.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":2134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 2,134 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":4059,"source":{"system":"sec-edgar","filing":"0000950170-25-077220","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000095017025077220/ownership.xml","form_type":"4"}},{"id":1441670,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-08-05T20:46:06.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $130,000 by a 30-day trailing average stock price."}],"balance_after":20698,"source":{"system":"sec-edgar","filing":"0001225208-24-007870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520824007870/doc4.xml","form_type":"4"}},{"id":1448257,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T22:40:44.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":7.91,"expiration_date":"2034-07-23","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-24-083099","document":"tm2420266-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465924083099/tm2420266-4_4seq1.xml","form_type":"4"}},{"id":1448256,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T22:40:44.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 24, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":32933,"source":{"system":"sec-edgar","filing":"0001104659-24-083099","document":"tm2420266-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465924083099/tm2420266-4_4seq1.xml","form_type":"4"}},{"id":1500926,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T21:30:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 23, 2025 or the date of the 2025 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1154,"derivative":{"exercise_price":137.53,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":1154},"source":{"system":"sec-edgar","filing":"0000950170-24-065397","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000095017024065397/ownership.xml","form_type":"4"}},{"id":1500925,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T21:30:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":732,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 732 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1925,"source":{"system":"sec-edgar","filing":"0000950170-24-065397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000095017024065397/ownership.xml","form_type":"4"}},{"id":1821033,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-07-31T20:57:37.000Z","date":"2023-07-31","kind":"grant","planned":false,"acquired":true,"shares":713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $130,000 by a 30-day trailing average stock price."}],"balance_after":20020,"source":{"system":"sec-edgar","filing":"0001225208-23-007784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520823007784/doc4.xml","form_type":"4"}},{"id":1853069,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T23:05:52.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":5.31,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-23-072403","document":"tm2318782-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465923072403/tm2318782-5_4seq1.xml","form_type":"4"}},{"id":1853068,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T23:05:52.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":20933,"source":{"system":"sec-edgar","filing":"0001104659-23-072403","document":"tm2318782-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465923072403/tm2318782-5_4seq1.xml","form_type":"4"}},{"id":1875311,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-30T20:31:38.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of May 25, 2024 or the date of the 2024 annual meeting of the stockholders of the Issuer, subject to continued service."}],"balance_after":1916,"derivative":{"exercise_price":71.33,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":1916},"source":{"system":"sec-edgar","filing":"0000950170-23-024885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000095017023024885/ownership.xml","form_type":"4"}},{"id":1875310,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T20:31:38.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":1193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 1,193 restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1193,"source":{"system":"sec-edgar","filing":"0000950170-23-024885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000095017023024885/ownership.xml","form_type":"4"}},{"id":2199661,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2022-08-01T19:03:25.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $130,000 by a three-month trailing average stock price."}],"balance_after":19307,"source":{"system":"sec-edgar","filing":"0001225208-22-009083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520822009083/doc4.xml","form_type":"4"}},{"id":2226001,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T00:10:24.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":26800,"derivative":{"exercise_price":3.43,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001104659-22-073152","document":"tm2218958-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465922073152/tm2218958-6_4seq1.xml","form_type":"4"}},{"id":2226000,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T00:10:24.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":8933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":8933,"source":{"system":"sec-edgar","filing":"0001104659-22-073152","document":"tm2218958-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465922073152/tm2218958-6_4seq1.xml","form_type":"4"}},{"id":2242860,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T20:32:42.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant, June 1, 2023, or the date of the following annual meeting of shareholders of the Company."}],"balance_after":13500,"derivative":{"exercise_price":28.12,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0000899243-22-021202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000089924322021202/doc4.xml","form_type":"4"}},{"id":2562346,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-22T12:19:56.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests over three years, vesting 1/3 on each yearly anniversary of the date of grant."}],"balance_after":36000,"derivative":{"exercise_price":10.02,"expiration_date":"2031-09-19","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-21-118130","document":"tm2128101-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000110465921118130/tm2128101-3_4seq1.xml","form_type":"4"}},{"id":2620710,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2021-08-02T20:48:00.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $110,000 by a three-month trailing average stock price."}],"balance_after":18288,"source":{"system":"sec-edgar","filing":"0001225208-21-011021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520821011021/doc4.xml","form_type":"4"}},{"id":2689653,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T21:19:10.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the shares subject to the option on January 1, 2022 and in equal monthly installments as to the remainder of the shares for two years thereafter."}],"balance_after":2250,"derivative":{"exercise_price":26.26,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0000899243-21-021342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000089924321021342/doc4.xml","form_type":"4"}},{"id":2713366,"issuer":{"id":4343,"kind":"organization","name":"BENCHMARK ELECTRONICS INC"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T16:40:35.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by a restricted stock unit award bearing the right to receive Common Shares and are scheduled to vest one-year from the date of grant."}],"balance_after":24489,"source":{"system":"sec-edgar","filing":"0001209191-21-032627","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863436/000120919121032627/doc4.xml","form_type":"4"}},{"id":2922321,"issuer":{"id":4261,"kind":"organization","name":"TransMedics Group, Inc.","symbol":"TMDX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T22:57:41.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter."}],"balance_after":18000,"derivative":{"exercise_price":19.9,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-21-000436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000089924321000436/doc4.xml","form_type":"4"}},{"id":3075881,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2020-07-27T18:29:13.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":1359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $110,000 by a three-month trailing average stock price."}],"balance_after":17494,"source":{"system":"sec-edgar","filing":"0001225208-20-009965","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520820009965/doc4.xml","form_type":"4"}},{"id":3149771,"issuer":{"id":4343,"kind":"organization","name":"BENCHMARK ELECTRONICS INC"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T19:04:47.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":7883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by a restricted stock unit award bearing the right to receive Common Shares and are scheduled to vest one-year from the date of grant."}],"balance_after":19289,"source":{"system":"sec-edgar","filing":"0001179110-20-005968","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863436/000117911020005968/edgar.xml","form_type":"4"}},{"id":3453860,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2019-07-30T14:04:15.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":1381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $110,000 by a twelve-month trailing average stock price."}],"balance_after":16135,"source":{"system":"sec-edgar","filing":"0001225208-19-010598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520819010598/doc4.xml","form_type":"4"}},{"id":3459375,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":4.8,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459374,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":4.36,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459373,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":6.84,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459372,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":6.12,"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459371,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":14.27,"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459370,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":13237,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares."}],"balance_after":0,"derivative":{"exercise_price":21.17,"underlying":"Common Stock","underlying_shares":13237},"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3459369,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-18T23:48:07.000Z","date":"2019-07-18","kind":"disposition_to_issuer","acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 18, 2019, pursuant to that certain Agreement and Plan of Merger dated April 26, 2019 (the \"Merger Agreement\") among Aratana Therapeutics, Inc. (the \"Company\"), Elanco Animal Health Incorporated (\"Elanco\") and Elanco Athens, Inc., a Delaware corporation and a direct wholly owned subsidiary of Elanco (\"Elanco Athens\"), Elanco Athens merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Elanco. Pursuant to the Merger Agreement, each outstanding share of Company common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive (A) 0.1481 validly issued, fully paid and non-assessable shares of Elanco common stock (the \"Stock Consideration\"), having a market value of $4.91 on the effective date of the Merger, and (B) one contingent value right, which represents the contractual right to receive a contingent cash (continued in footnote 2)"},{"field":"shares","element":"transactionShares","label":"F2","text":"(continued from footnote 1) payment of $0.25 per share of Company common stock if a specified milestone is achieved within agreed time periods, subject to and in accordance with the CVR Agreement, dated July 18, 2019, by and among Elanco, Broadridge Corporate Issuer Solutions, Inc., and UMB Bank, National Association (together with the Stock Consideration, the \"Merger Consideration\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of all outstanding unvested Company restricted stock awards was accelerated in full and each such restricted stock award was cancelled and terminated as of the effective time of the Merger. Each holder of a Company restricted stock award received the right to the Merger Consideration due with respect to the shares of Company common stock received in exchange for such accelerated restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 18, 2019, pursuant to that certain Agreement and Plan of Merger dated April 26, 2019 (the \"Merger Agreement\") among Aratana Therapeutics, Inc. (the \"Company\"), Elanco Animal Health Incorporated (\"Elanco\") and Elanco Athens, Inc., a Delaware corporation and a direct wholly owned subsidiary of Elanco (\"Elanco Athens\"), Elanco Athens merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Elanco. Pursuant to the Merger Agreement, each outstanding share of Company common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive (A) 0.1481 validly issued, fully paid and non-assessable shares of Elanco common stock (the \"Stock Consideration\"), having a market value of $4.91 on the effective date of the Merger, and (B) one contingent value right, which represents the contractual right to receive a contingent cash (continued in footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from footnote 1) payment of $0.25 per share of Company common stock if a specified milestone is achieved within agreed time periods, subject to and in accordance with the CVR Agreement, dated July 18, 2019, by and among Elanco, Broadridge Corporate Issuer Solutions, Inc., and UMB Bank, National Association (together with the Stock Consideration, the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-042721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119042721/doc4.xml","form_type":"4"}},{"id":3497642,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-07T21:55:59.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":4.8,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-035638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119035638/doc4.xml","form_type":"4"}},{"id":3497641,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T21:55:59.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-19-035638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919119035638/doc4.xml","form_type":"4"}},{"id":3522356,"issuer":{"id":4343,"kind":"organization","name":"BENCHMARK ELECTRONICS INC"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T20:13:02.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":5972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by a restricted stock unit award bearing the right to receive Common Shares and are scheduled to vest one-year from the date of grant."}],"balance_after":11406,"source":{"system":"sec-edgar","filing":"0001179110-19-006265","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/863436/000117911019006265/edgar.xml","form_type":"4"}},{"id":3858439,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2018-07-31T16:20:00.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":1356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $100,000 by a twelve-month trailing average stock price."}],"balance_after":14754,"source":{"system":"sec-edgar","filing":"0001225208-18-012037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520818012037/doc4.xml","form_type":"4"}},{"id":3859257,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-30T21:45:18.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":4.36,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-044449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919118044449/doc4.xml","form_type":"4"}},{"id":3859256,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-30T21:45:18.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13500,"source":{"system":"sec-edgar","filing":"0001209191-18-044449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919118044449/doc4.xml","form_type":"4"}},{"id":4247897,"issuer":{"id":44,"kind":"organization","name":"WATTS WATER TECHNOLOGIES INC","symbol":"WTS"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2017-08-01T20:25:51.000Z","date":"2017-08-01","kind":"grant","acquired":true,"shares":1569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the annual grant of a stock award to the Reporting Person as a non-employee director of the Issuer at the Issuer's first quarterly board meeting following the Annual Meeting of Stockholders. The number of shares awarded is determined by dividing $100,000 by a twelve-month trailing average stock price."}],"balance_after":13398,"source":{"system":"sec-edgar","filing":"0001225208-17-013079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/795403/000122520817013079/doc4.xml","form_type":"4"}},{"id":4273795,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-23T21:37:16.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests on the earlier of (i) the first anniversary of the date of grant and (ii) the day immediately preceding the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to continued service as a member of the Board of Directors of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":6.84,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-041738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919117041738/doc4.xml","form_type":"4"}},{"id":4273794,"issuer":{"id":155913,"kind":"organization","name":"ARATANA THERAPEUTICS, INC.","symbol":"PETX"},"owners":[{"id":26905,"kind":"person","name":"RAINES MERILEE","position":1,"cik":"0001023869","reported_name":"RAINES MERILEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-23T21:37:16.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-17-041738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023869/000120919117041738/doc4.xml","form_type":"4"}}]}